 | ALX Oncology Holdings Inc. | |||
| NMS : ALXO || Location: United States | ||||
$13.69+0.8 (+6.21%) |
0.61 M | 12.83 - 13.85 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.121 M |
| March 15, 2024 | 2.914 M |
| Feb. 29, 2024 | 3.478 M |
| Feb. 15, 2024 | 3.531 M |
| Jan. 31, 2024 | 3.620 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.86 | -0.93 | -8.35% |
| 09/30/2023 | -0.89 | -1.24 | -39.73% |
| 06/30/2023 | -0.90 | -0.84 | 6.42% |
| 03/31/2023 | -0.82 | -0.74 | 9.52% |
| 12/31/2022 | -0.90 | -0.75 | 17.03% |
ALXO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 50.152M | Shares Float | 22.300M |
| Short Float | 3.121M | Market Cap | 646.46M |
| Institution ownership | 97.60% | Insider ownership | 2.668% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.74 | Forward EPS | -2.96 |